Immupharma PLC Notice of AGM and posting of Report & Accounts (9079A)
June 04 2019 - 2:00AM
UK Regulatory
TIDMIMM
RNS Number : 9079A
Immupharma PLC
04 June 2019
4 JUNE 2019
ImmuPharma PLC
("ImmuPharma" or the "Company")
Notice of AGM and posting of Report & Accounts
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company confirms that the
Annual Report and Accounts for the year ended 31 December 2018, and
the Notice of Annual General Meeting has been posted to
shareholders.
These documents are available, in electronic form, for download
on the Company's website www.immupharma.co.uk.
ImmuPharma's Annual General Meeting will be held on Thursday 27
June at 10:30am (BST) at the offices of: Capital Access Group, 107
Cheapside, London, EC2V 6DN.
For further information please contact:
ImmuPharma PLC (www.immupharma.com) + 44 (0) 207 152 4080
Tim McCarthy, Chairman
Dimitri Dimitriou, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496
SPARK Advisory Partners Limited (NOMAD)
Neil Baldwin +44 (0) 203 368 8974
Vassil Kirtchev
Stanford Capital Partners (Joint Broker)
Patrick Claridge, John Howes +44 (0) 203 815 8880
SI Capital (Joint Broker)
Nick Emerson +44 (0) 1483 413500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DOCUORWRKOANRRR
(END) Dow Jones Newswires
June 04, 2019 02:00 ET (06:00 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2024 to Jun 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2023 to Jun 2024